New York: Pediatricians have reported the first known case of a woman, who received the first dose of the COVID-19 vaccine during pregnancy, giving birth to a baby with antibodies against the novel coronavirus.
According to the peer-reviewed study, posted in the medRxiv preprint server, the mother had received one dose of the Moderna mRNA vaccine at 36 weeks and three days of her gestation period.
Three weeks later, she gave birth to a healthy, healthy, full-time girl, and her blood sample taken immediately after birth showed antibodies against the SARS-CoV-2 virus, the study revealed. near.
Also Read | Why India needs to look east of Taiwan
“Here, we report on the first known case of infants with SARS-CoV-2 IgG antibodies detectable in cord blood after maternal vaccination,” co-authors Paul Gilbert and Chad Rudnick of University noted Florida Atlantic in the USA in mind.
The woman, who has only been feeding the baby, received the second dose of the vaccine according to the standard timeline of a 28-day vaccination protocol, the doctors noted.
Although earlier studies showed that the transfer of antibodies from COVID-recovered mothers to their fetuses through the placenta was lower than expected, the current research suggests “the ability to protect and reduce the risk of infection from SARS -CoV-2 with maternal vaccine. “
However, Gilbert and Rudnick note that more long-term studies are needed to measure antibody response in infants born to vaccinated mothers.
“The protective effect of newborns and the timing of maternal immunization are not yet known,” wrote the pediatricians in the study.
“We urge other researchers to create pregnancy and breastfeeding records as well as carry out efficacy and safety studies on the COVID-19 vaccines in pregnant and breastfeeding women and their children, “they said.
This story was published from a wire group group with no text changes. Only the headline has changed.